BioSpace News Archive

TrialScope has released a new version of its TrialScope DiscloseTM platform, featuring a revamped user interface (UI).

True Diagnostics, Inc. and Veravas announced their Strategic Alliance in the commercialization of VeraTest Biotin, a portable and easy-to-use digital qualitative test that can rapidly screen patient samples to determine if significant biotin is present, helping safeguard against potential biotin interference.

John Houston brings more than 30 years of experience in drug discovery and development in pharma and biotech as Cybrexa prepares to transition to become a clinical-stage company

$7.2 million total funding since 2015 for more providers of age-friendly healthcare

MLSC’s Milestone Achievement Program awards more than $1.9 million to 10 companies representing all major life sciences sectors

Global Blood Therapeutics, Inc. announced that it will present at the 2019 Morgan Stanley Global Healthcare Conference in New York City on Monday, September 9, 2019, at 2:50 p.m. Eastern Time.

Polyphor AG focused on the discovery and development of immuno-oncology compounds and a new class of antibiotics, publishes today its financial results for the first half of 2019 and announces a realignment of the strategy.

Ultragenyx Pharmaceutical Inc. announced positive data from the second dose cohort of the ongoing Phase 1/2 study of DTX401, an adeno-associated virus based gene therapy for the treatment of glycogen storage disease type Ia.

Atriva Therapeutics GmbH announced its participation in four upcoming partnering conferences worldwide.

Discngine announces that Lundbeck has selected its proprietary 3decision® collaborative platform to manage the pharma company’s structural knowledge related to protein and ligand 3D structures.